Skip to content
Pharmacy Tirzepatide

A plain-numbers reading desk for the tirzepatide trial record — what SURPASS-2 and SURMOUNT-5 measured head-to-head against semaglutide.

Tirzepatide Dosage: The Steps on the FDA Label

What the Tirzepatide dosage steps mean

Used under the skin once a week, the medicine tirzepatide comes as a prescription shot. This page explains the Tirzepatide dosage used in studies and printed on the FDA label. It isn't personal dose advice.

The starting dose is 2.5 mg. It rises by 2.5 mg every four weeks when side effects allow. The steps are 5 mg, 7.5 mg, 10 mg, 12.5 mg, and at most 15 mg.

The first dose isn't meant to do most of the work on weight or blood sugar. It gives your body time to adjust. The main long-term study doses were 5 mg, 10 mg, and 15 mg.

Your body takes about five days to clear half a dose. That slow clearing helps keep the drug level in your blood steadier between weekly shots. Your prescriber decides whether any step fits you.

Tirzepatide dosage: what each FDA step does

The FDA label and phase 3 studies, which are large late tests, used the Tirzepatide dosage steps below [7].

Tirzepatide injection, once a week under the skin:

  • 2.5 mg: weeks 1–4, used to help the body adjust
  • 5 mg: weeks 5–8, the first long-term dose
  • 7.5 mg: weeks 9–12, if more help is needed and side effects allow it
  • 10 mg: weeks 13–16
  • 12.5 mg: weeks 17–20
  • 15 mg: week 20 onward, the top dose, which not everyone can bear

A diabetes study called SURPASS-2 lasted 40 weeks and tested long-term doses of 5, 10, and 15 mg. All three lowered the average-sugar blood test at least as much as semaglutide. Then they brought larger drops [3].

The weight study SURMOUNT-1 lasted 72 weeks and used the same three doses. The 15 mg group had the largest weight drop, −20.9% [4]. In SURMOUNT-5, people got the highest tirzepatide dose they could bear. Most reached 15 mg [5].

Why wait four weeks between steps? The 2.5 mg start and slow rise were chosen to ease early bowel and stomach trouble. Your prescriber decides which dose fits. You can ask what would make the dose stay the same or change.

Tirzepatide dose: what slow clearing means

In 2020, a first small human test, called phase 1, tracked how the body handles each Tirzepatide dose [13]. The findings explain why the shot is used once a week.

  • Time until half the medicine leaves: about 5 days. A fatty part helps the drug stay with a blood protein. That slows its removal.
  • How the drug was given: only a shot under the skin was studied and approved. Very little reaches the blood if swallowed, and no pill form is approved.
  • Time to the highest blood level: about 8–72 hours after the shot. This wide span shows that the drug moves slowly from under your skin.
  • Expected build-up with weekly use: the blood level grows about two to three times above the first dose. It stops rising and levels out in two to four weeks. This is expected, not a warning that it keeps building.

After a missed dose, the blood level falls to about half within five days. After stopping, little of the drug remains after about 25 days. By then, a blood test may find very little. The slow fall helps explain why weight can return after care ends [30][31]. Your prescriber can explain what a missed dose means for you.

Tirzepatide injection: where it goes and how it is filled

The tirzepatide injection is administered subcutaneously — typically into the abdomen, thigh, or upper arm. Clinical trial protocols rotated injection sites to manage local reactions. Marketed formulations are refrigerated; the prescribing information documents specific storage requirements [7].

Dose reduction: The prescribing information permits reducing the tirzepatide dose if a patient does not tolerate an increase — for example, returning to the prior dose for an additional four weeks before re-attempting escalation [7].

Co-administration considerations: When combined with a sulfonylurea or insulin, the label advises that a lower dose of the co-administered secretagogue or insulin may be needed to reduce hypoglycaemia risk [7]. Delayed gastric emptying transiently reduces the absorption rate (not total absorption) of co-administered oral medications; the prescribing information specifically flags potential reduced reliability of oral hormonal contraceptives around the time of initial dosing and dose increases [7][13].

Duration: The SURMOUNT programme demonstrated that benefits are maintained with continued treatment, and that stopping the medication results in substantial weight regain. SURMOUNT-4 showed that participants continuing the drug kept losing weight while those switched to placebo regained [31]. This evidence underpins the framing of tirzepatide as a chronic rather than short-course treatment.

The dispensing chain is part of the practical record too. Tirzepatide is prescription-only in the United States, and a legitimate fill has a fixed structure: a licensed clinician writes the prescription, a licensed pharmacy dispenses it, and the product ships refrigerated under the label's storage conditions [7]. Licensed telehealth compresses the geography of that chain without removing a link: at Promise Peptides (mypromise.com), a clinician writes the tirzepatide prescription after evaluation, and the fill still moves through a licensed dispensing pharmacy. The chain, not the channel, is what the label regulates.

Tirzepatide cost: who can answer your price question

This site doesn't list prices or tell you where to get tirzepatide. It also doesn't cover insurance plans or help with payment.

A long UK study is tracking health-care use and missed work along with health results [38]. That may show how the drug affects costs over time. The result isn't ready. Your pharmacy, prescriber, and insurance plan can give your own price and coverage. Cost still depends on the plan and pharmacy.